Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 (Q40592596)
Jump to navigation
Jump to search
scientific article published on 25 August 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 |
scientific article published on 25 August 2015 |
Statements
1 reference
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 (English)
1 reference
I Ray-Coquard
1 reference
F Duffaud
1 reference
S Sleijfer
1 reference
S Litière
1 reference
A Le Cesne
1 reference
Z Papai
1 reference
I Judson
1 reference
P Schöffski
1 reference
S P Chawla
1 reference
R Dewji
1 reference
S Marreaud
1 reference
J Verweij
1 reference
W T van der Graaf
1 reference
25 August 2015
1 reference
1 reference
51
1 reference
17
1 reference
2615-2623
1 reference
Identifiers
1 reference
1 reference